Our neurotoxic world (part one): Chemotherapy and the brainOur neurotoxic world (part one): Chemotherapy and the brain
All In The Mind
Your brain is a resilient organ, but vulnerable to nasty environmental insults too. This week, in the first of two shows navigating our neurotoxic world: it's been dubbed 'Chemofog' and 'Chemobrain' by cancer survivors: short-term memory loss, foggy thoughts, fatigue - lingering sometimes years after chemotherapy. Could chemo be doing more than killing off cancer cells? New research suggests it may be more toxic to your nerve cells than cancer itself. Natasha Mitchell investigates.
30:05•10 Feb 2007
Chemobrain, Cancer and the Curious Case of the Foggy Mind
Episode Overview
- Some cancer survivors report ongoing issues like forgetfulness, mental fog and slower thinking long after chemotherapy has finished.
- Clinicians highlight that chemotherapy is potentially curative for many cancers but agree cognitive complaints are common and deserve serious study.
- Research in mice shows certain chemotherapy drugs can damage brain progenitor cells and myelin, sometimes more than the cancer cells being targeted.
- Hormonal changes, premature menopause, stress and multitasking demands may also contribute to cognitive problems, making it hard to isolate chemotherapy as the sole cause.
- Early brain‑scan studies suggest people who have had chemotherapy may use different brain regions during memory tasks, but the real‑life meaning of these changes is still unclear.
“"What we have now done is to say, yes, biologically, this is a problem. This is how we can study it."”
What can we learn from those who have battled addiction? Here, the focus shifts to a different kind of brain struggle: the mental fallout some people report after chemotherapy. All In The Mind brings together personal stories, cutting‑edge lab work and cautious clinical views to ask what’s really going on with so‑called "chemo brain" or "chemo fog".
Cancer survivor Denise Wong talks about finding a breast lump "by chance" and later feeling as if her mind had changed: "short‑term memory loss… narrowing of my vocabulary… it's just harder to express yourself and your thought processes are a lot slower"—years after treatment.
You’ll also hear from medical oncologists Dr Jeanette Vardy and Associate Professor Kelly (Callie) Phillips, who both stress that chemotherapy is a lifesaving treatment, yet acknowledge that some patients struggle with concentration and memory long after the nausea has settled. They unpack why pinning the blame on chemo alone is so tricky—hormonal changes, stress, early menopause and the sheer pressure of juggling work and young families all muddy the waters. Neuroscientist Professor Mark Noble adds a stark laboratory perspective.
His team’s mouse research suggests that common chemotherapy drugs can be "more vulnerable" to nerve cells than some cancer cells, damaging brain progenitor cells and myelin at doses below those used in clinics. At the same time, he warns against panic and points to promising ideas like antioxidants and ways to better shield healthy brain cells.
The style is conversational but thorough, mixing science chat, real‑life anecdotes and gentle humour (yes, "just blame it on the chemo brain") while never losing sight of the seriousness of cancer treatment and mental health.
If you or someone you care about is dealing with cancer, long‑term side‑effects, or worries about the brain, this honest, questioning conversation might help you frame better questions for your own doctors and reflect on how you look after your head as well as your body.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.